Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Open Book Extracts
AddedFeb 15, 2024
UpdatedJun 18, 2026
Open Book Extracts

Open Book Extracts

Series C

OBX: A cGMP-certified, vertically integrated cannabis manufacturer, offering premium plant-based products globally.

HQ
Roxboro, NC, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Open Book Extracts (OBX) was founded with the mission to be a premier cannabis manufacturer and processor, offering premium plant-based products. The company is cGMP certified and vertically integrated, controlling the entire supply chain from cultivation to final product. Located near North Carolina’s Research Triangle, OBX specializes in contract manufacturing, ingredient production, product development, and R&D. Their state-of-the-art extraction campus and proprietary refinement methods support a growing IP portfolio, making them a trusted partner for global brands.

Notable affiliated people include a team of Ph.D. chemists and seasoned business leaders who drive innovation and quality. Key investors and partnerships have bolstered OBX’s capabilities and market reach. The company has achieved significant milestones, including a robust client base spanning multiple countries and a reputation for excellence in the cannabis industry. OBX’s overall impact is marked by its ability to provide high-quality, reliable products to brands that prioritize efficacy and care.

Open Book Extracts - Similar Companies

Bristol Extracts logo

Bristol Extracts

GaXtracts logo

GaXtracts

gaxtracts.com

Outlier Biopharma logo

Outlier Biopharma

Central Processors logo

Central Processors

Cumberland Extracts logo

Cumberland Extracts

urbanXtracts logo

urbanXtracts

urbanxtracts.com

C3 Industries logo

C3 Industries

c3industries.com

Mile High Labs logo

Mile High Labs

milehighlabs.com

Bespoke Extracts logo

Bespoke Extracts

Kria Botanicals logo

Kria Botanicals

kriabotanicals.com

Maine Extraction logo

Maine Extraction

Oxbow Reserve logo

Oxbow Reserve

Groundworks Industries logo

Groundworks Industries

gw-ind.com

Hemp Synergistics logo

Hemp Synergistics

Whole Plants logo

Whole Plants

Open Book Extracts - Quick Facts

Who are Open Book Extracts' competitors?

Companies similar to Open Book Extracts include Bristol Extracts, GaXtracts, Outlier Biopharma and Central Processors.

When was Open Book Extracts founded?

Open Book Extracts was founded in 2019.

Where is Open Book Extracts' headquarters located?

Open Book Extracts' headquarters is located in Roxboro, NC, US.

How much has Open Book Extracts raised to-date?

As of Sep 2, 2022, Open Book Extracts has raised a total of $11.5M (USD).

How many employees does Open Book Extracts have?

Open Book Extracts has 70 employees as of Feb 4, 2024.

Open Book Extracts - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
Geographic Exposure
  • Global
Model
  • Manufacturing
  • Platform
Revenue
  • Licensing
Customer
  • Enterprise
Main Product
  • Cannabis Products
Tags
  • Biotech
NAICS
  • 459900Other Miscellaneous Retailers
  • 459990All Other Miscellaneous Retailers
  • 459991Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers
  • 450000Retail Trade
  • 459000Sporting Goods, Hobby, Musical Instrument, Book, and Miscellaneous Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 620000Health Care and Social Assistance